Jupiter Research Capital (Asia) Ltd’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Jupiter Research Capital (Asia) Ltd's HAE Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Haemonetics (HAE) in Q3 2026, closing a stake of 23,450 shares — an estimated $1.76M sold.
Jupiter Research Capital (Asia) Ltd first reported a position in HAE in Q2 2026 and held it in 1 quarter. The position peaked at $1.76M in Q2 2026. 334 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Haemonetics position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 23,450 Haemonetics shares in Q3 2026, an estimated $1.76M.
- Jupiter Research Capital (Asia) Ltd first reported a position in Haemonetics in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's Haemonetics position peaked at $1.76M in Q2 2026.
- 334 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.